Prospective real-world cohort of immuno-(chemo) therapy (IO) prior to resection, definitive chemo-radiotherapy (CRT), or palliative therapy in patients with non-small cell lung cancer (NSCLC) without a primary curative option

ONCOLOGY RESEARCH AND TREATMENT(2022)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要